Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer

NCT03542799 is registered in ClinicalTrials.gov with Shenzhen Second People's Hospital as lead sponsor.

NCT NCT03542799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
Lead sponsor
Shenzhen Second People's Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
May 22, 2018
Completion date
May 23, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer